NF-κB as a potential therapeutic target in microbial diseases.
about
Targeting the Brain Reservoirs: Toward an HIV CureDifferential transcriptomic response in the spleen and head kidney following vaccination and infection of Asian seabass with Streptococcus iniae.Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genesMicrobe-host interactions: structure and role of Gram-negative bacterial porinsCellular responses to Sindbis virus infection of neural progenitors derived from human embryonic stem cells.Inhibition of influenza virus via a sesquiterpene fraction isolated from Laggera pterodonta by targeting the NF-κB and p38 pathways.NF-κB Has a Direct Role in Inhibiting Bmp- and Wnt-Induced Matrix Protein Expression.Protective effect of α-lipoic acid against radiation-induced fibrosis in mice.Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survivalOrphan PTMs: Rare, yet functionally important modifications of cysteine.Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Thrombin induces ICAM-1 expression in human lung epithelial cells via c-Src/PDGFR/PI3K/Akt-dependent NF-κB/p300 activation.Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival.Lipopolysaccharide induces ICAM-1 expression via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human pulmonary alveolar epithelial cells.Signalling Profiles of Blood Leucocytes in Sepsis and in Acute Pancreatitis in Relation to Disease Severity.Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
P2860
Q28075694-97B52F21-7123-4414-A0D9-E03779F06ED2Q33843222-66986E50-4E3D-4B4F-AE1F-12D0C071096CQ34237741-5BD2E7BD-EA6D-49DE-8598-50ED054978B7Q34321941-A23F47B2-5795-4559-8C37-D679BD28D2F1Q35365857-0C7F1562-128E-4054-B586-F5BFD149C08BQ36243179-3A210915-6839-4475-BA91-28FED061349BQ36464006-371EC9EE-EBC2-424C-B922-840E07054BB1Q37085820-3505471F-4282-4F6F-8830-017E447290A7Q37547432-A09FFF39-0D1A-4A2F-9DFD-BB04348DFB8BQ38096950-A851CE5A-01E2-4F53-A597-60C477FBD071Q38856263-75642B07-9C91-476D-B7BD-E955EDEB8825Q39026115-47AB0526-B645-406B-9D9A-F86FD461B1FCQ42081850-292D0B43-6542-4881-A8BF-E1D710724CC5Q46613152-0941D886-601D-44CD-BDAD-40C32AB4A659Q48203151-577DD2C3-C2F6-4130-B415-FD61B6B98754Q55394771-2A89D95F-5201-4FF4-AFE8-D400E27215E5
P2860
NF-κB as a potential therapeutic target in microbial diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
NF-κB as a potential therapeutic target in microbial diseases.
@en
NF-κB as a potential therapeutic target in microbial diseases.
@nl
type
label
NF-κB as a potential therapeutic target in microbial diseases.
@en
NF-κB as a potential therapeutic target in microbial diseases.
@nl
prefLabel
NF-κB as a potential therapeutic target in microbial diseases.
@en
NF-κB as a potential therapeutic target in microbial diseases.
@nl
P2093
P2860
P356
P1433
P1476
NF-κB as a potential therapeutic target in microbial diseases.
@en
P2093
Emiliana Finamore
Mariateresa Vitiello
Marilena Galdiero
Massimiliano Galdiero
Stefania Galdiero
P2860
P304
P356
10.1039/C2MB05335G
P577
2012-02-06T00:00:00Z